Apredica Acquires Cellumen | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Contract research organization Apredica announced today that it has acquired the intellectual property and related assets of Cellumen for an undisclosed sum.

The acquisition provides Apredica with Cellumen's Cellular Systems Biology and high-content toxicology services and technologies. Specifically, Watertown, Mass.-based Apredica said that the deal will "significantly strengthen" the firm's high-content toxicology offerings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.